Clinical Trials in Denver

Showing 1841-1860 of 8,669 trials

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

NCT05406583

This study will test an anti-HIV drug (ARV) for newborn babies. The study will include a minimum of 36 and up to 108 mothers living with HIV and their newborn babies from Brazil, South Africa, Thailand, and the United States. Infants will be in the study for approximately 16 weeks (four months) after they are born. Mothers will not receive study drug and will exit the study after the Entry visit.

HIV

National Institute of Allergy and Infectious Diseases (NIAID)48 participantsStarted Oct 2022

Los Angeles, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +12 more locations

TERMINATEDPhase 18.4 miles

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

NCT04458259

A First-in-Human Pharmacokinetic, Safety, and Tolerability Study of PF-07265807 as Monotherapy and in Combination in Participants with Advanced or Metastatic Solid Tumors

Neoplasm Metastasis

Pfizer88 participantsStarted Sep 2020

Fayetteville, Arkansas, United States • Fayetteville, Arkansas, United States • Rogers, Arkansas, United States +30 more locations

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Find Trials by Condition in Denver

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

A Study of LY3549492 in Healthy Weight Adult Participants

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2